Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
N Engl J Med 2019 Aug 8
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease.
Related Questions
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
Hb at goal of 9-10
New answer
by at University of Pittsburgh (August 7, 2024)
First, it would be important to assess whether there may be non-medical reasons for the frequent VOC. As you know, psychosocial factors are important determinants of health in...
Read more (2 Answers available)
17198
×
To continue please login or register
Register
or
Sign in